EW
SANA icon

Evoke Wealth’s Sana Biotechnology SANA Stock Holding History

Evoke Wealth’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$110K Sell
38,184
-385
-1% -$1.52K ﹤0.01% 692
2025
Q4 		$157K Buy
+38,569
New +$173K ﹤0.01% 651

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Evoke Wealth's SANA Position: Q1 2026 in Review

Evoke Wealth reduced its Sana Biotechnology (SANA) stake by 1% in Q1 2026, selling an estimated $1.52K and leaving 38,184 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #692.

Evoke Wealth first reported a position in SANA in Q4 2025 and has held it in 2 quarters since. The position peaked at $157K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Evoke Wealth held 38,184 shares of Sana Biotechnology worth $110K as of Q1 2026.
  • Evoke Wealth sold 385 Sana Biotechnology shares in Q1 2026, an estimated $1.52K.
  • Sana Biotechnology made up ﹤0.01% of Evoke Wealth's portfolio in Q1 2026, its #692 holding.
  • Evoke Wealth first reported a position in Sana Biotechnology in Q4 2025 and has held it in 2 quarters since.
  • Evoke Wealth's Sana Biotechnology position peaked at $157K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.